Know When to Use Different Immune Thrombocytopenia (ITP) Treatments

November 2019

You'll get questions about strategies to manage primary immune thrombocytopenia (ITP) in adults.

These patients have platelets under 100,000/mm3 not linked to an identifiable cause...such as heparin or other meds, infections, or lupus.

Assess bleeding risk and platelet count when considering treatment...and work closely with the hematologist.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote